Is self-administration of subcutaneous immunoglobulin therapy safe in a home care setting?
Clinical practice based on best evidence can help ensure that patients receive safe and appropriate care from nurses. Members of a nursing inquiry council at a pediatric-based organization addressed the issue of patient-administered immunoglobulin therapy in the home care setting through conducting an evidence-based practice (EBP) project. Following the steps of EBP, an EBP change was implemented that allowed families the option of immunoglobulin therapy administration by the patient (or a caregiver) or a home healthcare nurse. Outcomes measured indicated that self-administration positively impacted patient and family satisfaction and posed no additional safety risks.